Application no. and date | 03714148.8 (espacenet) (Federated) (European Patent Register), 20030313 | Patent/reg. no. and date | DK/EP 1482932, 20091125 | Publication date | 20041208 | Priority no. and date | US 364007 P, 20020313 | EP pub. no. and date |
EP 1482932 20041208 | Effective date | | Applicant/owner | Array BioPharma Inc., 3200 Walnut Street
Boulder, CO 80301, US, AstraZeneca AB, Västra Mälarehamnen 9
151 85 Södertälje, SE | Applicant ref. no. | 113037 | Inventor | WALLACE, Eli, M., P.O. Box 1727
Lyons, CO 80540, US, LYSSIKATOS, Joseph, P., 1720 Eldorado Circle
Superior, CO 80027, US, HURLEY, Brian, T., 3725 Birchwood Drive, 22
Boulder, CO 80304, US, MARLOW, Allison, L., 2722 Juniper Avenue, 57
Boulder, CO 80304, US | Representative | Budde Schou A/S, Dronningens Tværgade 30, 1302 København K | Opponent | | IPC Class | A61K 31/4184 (2006.01) , A61P 35/00 (2006.01) , C07D 235/04 (2006.01) , C07D 235/06 (2006.01) | Title | N3-alkylerede benzimidazolderivater som MEK-inhibitorer | Int. application no. | US2003007864 | Int. publication no. | WO2003077914 | Related patent (certificate) | CA 2019 00011 | Status | Udløbet | Pædiatrisk forlængelse | - | Udløbsdato for pædiatrisk forlængelse | - |
|